ResMed, Inspire Medical fall after Lilly’s Zepbound gains sleep apnea indication

by
Contributor since / Followers

2 days ago

ResMed (NYSE:RMD) and Inspire Medical Systems (NYSE:INSP), two companies reliant on sleep apnea devices, are down in Monday trading after Eli Lilly’s (LLY) Zepbound (tirzepatide) gained an additional indication for sleep apnea in obese individuals on Dec. 20.
ResMed and

Tags: LLY